CELLECTAR BIOSCIENCES INC (CLRB) Stock Cash Flow
NASDAQ:CLRB - Nasdaq - US15117F8077 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -49.67M | -37.98M | -28.60M | -24.12M | -15.09M | |||
| Depreciation Amortization | 295.46K | 192.38K | 150.00K | 150.00K | 140.00K | |||
| Change In Working Capital | -76.35K | 3.48M | 1.68M | 200.00K | 670.00K | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other non cash items | 3.19M | 1.94M | 1.55M | 1.20M | 350.00K | |||
| OPERATING CASH FLOW | -46.27M | -32.38M | -25.22M | -22.57M | -13.93M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -306.95K | -864.04K | -230.00K | -140.00K | -60.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -306.95K | -864.04K | -230.00K | -140.00K | -60.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 180.00K | |||
| Stock Issued/Repurchased | 61.85M | 22.94M | 9.61M | 1.25M | 60.36M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 61.85M | 22.94M | 9.61M | 1.25M | 60.55M | |||
| CHANGE IN CASH | 15.28M | -10.30M | -15.84M | -21.46M | 46.56M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -46.27M | -32.38M | -25.22M | -22.57M | -13.93M | |||
| Capital Expenditure | -306.95K | -864.04K | -230.00K | -140.00K | -60.00K | |||
| FREE CASH FLOW | -46.57M | -33.24M | -25.45M | -22.71M | -13.99M | |||
All data in USD